IL92474A - Reaction method and combination for determining nucleotide sequences - Google Patents

Reaction method and combination for determining nucleotide sequences

Info

Publication number: IL92474A
Authority: IL; Israel
Prior art keywords: nucleic acid; target nucleic; attachment; primer; sequencing
Prior art date: 1988-11-29

Application number

IL9247489A

Other languages

English (en)

Hebrew (he)

Other versions

IL92474A0 (en

Original Assignee

Orion Yhtymae Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-29

Filing date

1989-11-27

Publication date

1994-04-12

1989-11-27 Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy

1990-08-31 Publication of IL92474A0 publication Critical patent/IL92474A0/xx

1994-04-12 Publication of IL92474A publication Critical patent/IL92474A/en

Links

238000000034 method Methods 0.000 title claims abstract description 92
108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 7
239000003153 chemical reaction reagent Substances 0.000 title claims description 14
238000012163 sequencing technique Methods 0.000 claims abstract description 83
150000007523 nucleic acids Chemical class 0.000 claims abstract description 74
102000039446 nucleic acids Human genes 0.000 claims abstract description 69
108020004707 nucleic acids Proteins 0.000 claims abstract description 69
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 62
230000003321 amplification Effects 0.000 claims abstract description 61
108020004414 DNA Proteins 0.000 claims abstract description 46
108091033319 polynucleotide Proteins 0.000 claims abstract description 43
102000040430 polynucleotide Human genes 0.000 claims abstract description 43
239000002157 polynucleotide Substances 0.000 claims abstract description 43
239000011159 matrix material Substances 0.000 claims abstract description 38
239000002773 nucleotide Substances 0.000 claims abstract description 31
125000003729 nucleotide group Chemical group 0.000 claims abstract description 31
229920000642 polymer Polymers 0.000 claims abstract description 30
239000000203 mixture Substances 0.000 claims abstract description 22
239000007787 solid Substances 0.000 claims abstract description 19
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 18
238000006116 polymerization reaction Methods 0.000 claims abstract description 14
238000004925 denaturation Methods 0.000 claims abstract description 13
230000036425 denaturation Effects 0.000 claims abstract description 13
230000002194 synthesizing effect Effects 0.000 claims abstract description 6
238000001712 DNA sequencing Methods 0.000 claims abstract description 4
239000000523 sample Substances 0.000 claims description 27
230000000295 complement effect Effects 0.000 claims description 17
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 15
102000004190 Enzymes Human genes 0.000 claims description 9
108090000790 Enzymes Proteins 0.000 claims description 9
238000004458 analytical method Methods 0.000 claims description 9
108090001008 Avidin Proteins 0.000 claims description 8
238000000137 annealing Methods 0.000 claims description 8
229960002685 biotin Drugs 0.000 claims description 8
239000011616 biotin Substances 0.000 claims description 8
239000001226 triphosphate Substances 0.000 claims description 8
235000011178 triphosphate Nutrition 0.000 claims description 8
235000020958 biotin Nutrition 0.000 claims description 7
102000053602 DNA Human genes 0.000 claims description 5
108010090804 Streptavidin Proteins 0.000 claims description 5
239000013522 chelant Substances 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
230000002255 enzymatic effect Effects 0.000 claims description 4
230000005291 magnetic effect Effects 0.000 claims description 4
229910052751 metal Inorganic materials 0.000 claims description 4
239000002184 metal Substances 0.000 claims description 4
-1 nucleoside triphosphates Chemical class 0.000 claims description 4
206010069754 Acquired gene mutation Diseases 0.000 claims description 3
238000002372 labelling Methods 0.000 claims description 3
230000037439 somatic mutation Effects 0.000 claims description 3
238000003975 animal breeding Methods 0.000 claims description 2
238000004374 forensic analysis Methods 0.000 claims description 2
244000005700 microbiome Species 0.000 claims description 2
238000003976 plant breeding Methods 0.000 claims description 2
241000894007 species Species 0.000 claims description 2
230000003100 immobilizing effect Effects 0.000 claims 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 4
239000002777 nucleoside Substances 0.000 claims 3
230000006820 DNA synthesis Effects 0.000 claims 1
230000001351 cycling effect Effects 0.000 claims 1
238000001668 nucleic acid synthesis Methods 0.000 claims 1
238000001514 detection method Methods 0.000 abstract description 8
238000003752 polymerase chain reaction Methods 0.000 abstract description 6
238000012986 modification Methods 0.000 abstract description 4
230000004048 modification Effects 0.000 abstract description 4
239000000376 reactant Substances 0.000 abstract description 3
239000013615 primer Substances 0.000 description 95
238000006243 chemical reaction Methods 0.000 description 57
239000012634 fragment Substances 0.000 description 28
239000011324 bead Substances 0.000 description 14
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 12
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 12
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 11
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 11
239000002245 particle Substances 0.000 description 11
239000000243 solution Substances 0.000 description 11
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 8
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 8
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 8
238000001962 electrophoresis Methods 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 8
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
239000000499 gel Substances 0.000 description 7
239000000047 product Substances 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
239000004793 Polystyrene Substances 0.000 description 6
239000002585 base Substances 0.000 description 6
239000000463 material Substances 0.000 description 6
229920002223 polystyrene Polymers 0.000 description 6
238000009739 binding Methods 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
230000010076 replication Effects 0.000 description 5
238000010561 standard procedure Methods 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 5
241000701022 Cytomegalovirus Species 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
239000005546 dideoxynucleotide Substances 0.000 description 4
238000002955 isolation Methods 0.000 description 4
239000011859 microparticle Substances 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
238000000746 purification Methods 0.000 description 4
239000000725 suspension Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
108700028369 Alleles Proteins 0.000 description 3
102000013918 Apolipoproteins E Human genes 0.000 description 3
108010025628 Apolipoproteins E Proteins 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
239000013504 Triton X-100 Substances 0.000 description 3
229920004890 Triton X-100 Polymers 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
238000001502 gel electrophoresis Methods 0.000 description 3
230000007614 genetic variation Effects 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
238000000926 separation method Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000013598 vector Substances 0.000 description 3
238000003260 vortexing Methods 0.000 description 3
OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 2
101710095339 Apolipoprotein E Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
206010071602 Genetic polymorphism Diseases 0.000 description 2
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
241000589500 Thermus aquaticus Species 0.000 description 2
HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 2
ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 2
238000013459 approach Methods 0.000 description 2
230000037429 base substitution Effects 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
125000005647 linker group Chemical group 0.000 description 2
238000007885 magnetic separation Methods 0.000 description 2
238000005497 microtitration Methods 0.000 description 2
230000035772 mutation Effects 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 2
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102100029470 Apolipoprotein E Human genes 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
101100173928 Caulobacter vibrioides (strain ATCC 19089 / CB15) fljO gene Proteins 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000012369 In process control Methods 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000010965 in-process control Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
JTGUPKKZPSNUIX-UHFFFAOYSA-N methylperoxyphosphonamidous acid Chemical compound COOP(N)O JTGUPKKZPSNUIX-UHFFFAOYSA-N 0.000 description 1
239000011325 microbead Substances 0.000 description 1
239000000178 monomer Substances 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
238000001821 nucleic acid purification Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000002987 primer (paints) Substances 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000007790 solid phase Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL9247489A 1988-11-29 1989-11-27 Reaction method and combination for determining nucleotide sequences IL92474A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27764388A	1988-11-29	1988-11-29

Publications (2)

Publication Number	Publication Date
IL92474A0 IL92474A0 (en)	1990-08-31
IL92474A true IL92474A (en)	1994-04-12

Family

ID=23061771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9247489A IL92474A (en)	1988-11-29	1989-11-27	Reaction method and combination for determining nucleotide sequences

Country Status (14)

Country	Link
EP (1)	EP0371437B1 (da)
JP (1)	JP2766003B2 (da)
AT (1)	ATE134388T1 (da)
AU (1)	AU623200B2 (da)
CA (1)	CA2004056C (da)
DE (1)	DE68925717T2 (da)
DK (1)	DK175170B1 (da)
ES (1)	ES2082766T3 (da)
FI (1)	FI97153C (da)
GR (1)	GR3019105T3 (da)
IL (1)	IL92474A (da)
NO (1)	NO176362C (da)
NZ (1)	NZ231576A (da)
PT (1)	PT92420B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8801070D0 (sv) *	1988-03-23	1988-03-23	Pharmacia Ab	Method for immobilizing a dna sequence on a solid support
DE3816934A1 (de) *	1988-05-18	1989-11-23	Ramalho Ortigao Jose Flavio	Neue sequenzierungsmethode fuer einzel- oder doppelstraengige nucleinsaeuren an fester phase
US5858652A (en) *	1988-08-30	1999-01-12	Abbott Laboratories	Detection and amplification of target nucleic acid sequences
US5547839A (en)	1989-06-07	1996-08-20	Affymax Technologies N.V.	Sequencing of surface immobilized polymers utilizing microflourescence detection
US6013431A (en)	1990-02-16	2000-01-11	Molecular Tool, Inc.	Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
IL97222A (en) *	1990-02-16	1995-08-31	Orion Yhtymae Oy	Method and reagent for determining specific nucleotide variations
GB9017788D0 (en) *	1990-08-14	1990-09-26	Medical Res Council	Method for preparing,isolating and sequencing polynucleotides
US6004744A (en)	1991-03-05	1999-12-21	Molecular Tool, Inc.	Method for determining nucleotide identity through extension of immobilized primer
WO1992020820A1 (en) *	1991-05-15	1992-11-26	Vanderbilt University	Method to determine metastatic potential of tumor cells
US5569582A (en) *	1991-07-15	1996-10-29	Institute Of Molecular Biology & Technology	Rapid amplification and detection of nucleic acids
AU660484B2 (en) *	1991-07-24	1995-06-29	University Partnerships Pty Ltd	Single step amplification and sequencing of nucleic acids
WO1993002212A1 (en) *	1991-07-24	1993-02-04	University Partnerships Pty. Ltd.	Single step amplification and sequencing of nucleic acids
DE4214112A1 (de) *	1991-08-02	1993-02-04	Europ Lab Molekularbiolog	Neues verfahren zur sequenzierung von nukleinsaeuren
GB9122060D0 (en) *	1991-10-17	1991-11-27	Dynal As	Method of sequencing double stranded dna
GB9207598D0 (en) *	1992-04-03	1992-05-20	Dynal As	Method of sequencing double stranded dna
GB9210176D0 (en) †	1992-05-12	1992-06-24	Cemu Bioteknik Ab	Chemical method
US5843640A (en) *	1992-06-19	1998-12-01	Northwestern University	Method of simultaneously detecting amplified nucleic acid sequences and cellular antigens in cells
US6436635B1 (en)	1992-11-06	2002-08-20	Boston University	Solid phase sequencing of double-stranded nucleic acids
US5795714A (en)	1992-11-06	1998-08-18	Trustees Of Boston University	Method for replicating an array of nucleic acid probes
CA2158642A1 (en) *	1993-03-19	1994-09-29	Hubert Koster	Dna sequencing by mass spectrometry via exonuclease degradation
ES2078185B1 (es) *	1994-05-06	1996-08-16	Inia	Procedimiento para la tipificacion molecular de patogenos virales con genoma rna y de patogenos subvirales mediante sintesis aleatoria de cdna.
ATE220424T1 (de) *	1994-05-28	2002-07-15	Tepnel Medical Ltd	Herstellung von nukleinsaeurekopien
US7803529B1 (en)	1995-04-11	2010-09-28	Sequenom, Inc.	Solid phase sequencing of biopolymers
US6077664A (en) *	1995-06-07	2000-06-20	Promega Corporation	Thermophilic DNA polymerases from Thermotoga neapolitana
US6001645A (en) *	1995-06-07	1999-12-14	Promega Corporation	Thermophilic DNA polymerases from thermotoga neapolitana
SE9504099D0 (sv)	1995-11-16	1995-11-16	Pharmacia Biotech Ab	A method of sequencing
WO1997035033A1 (en)	1996-03-19	1997-09-25	Molecular Tool, Inc.	Method for determining the nucleotide sequence of a polynucleotide
US7381525B1 (en)	1997-03-07	2008-06-03	Clinical Micro Sensors, Inc.	AC/DC voltage apparatus for detection of nucleic acids
US6096273A (en)	1996-11-05	2000-08-01	Clinical Micro Sensors	Electrodes linked via conductive oligomers to nucleic acids
US6140053A (en)	1996-11-06	2000-10-31	Sequenom, Inc.	DNA sequencing by mass spectrometry via exonuclease degradation
US20060275782A1 (en)	1999-04-20	2006-12-07	Illumina, Inc.	Detection of nucleic acid reactions on bead arrays
WO2000063437A2 (en)	1999-04-20	2000-10-26	Illumina, Inc.	Detection of nucleic acid reactions on bead arrays
AU779220B2 (en)	1999-07-26	2005-01-13	Clinical Micro Sensors, Inc.	Sequence determination of nucleic acids using electronic detection
US7244559B2 (en)	1999-09-16	2007-07-17	454 Life Sciences Corporation	Method of sequencing a nucleic acid
US7211390B2 (en)	1999-09-16	2007-05-01	454 Life Sciences Corporation	Method of sequencing a nucleic acid
US6518024B2 (en)	1999-12-13	2003-02-11	Motorola, Inc.	Electrochemical detection of single base extension
ATE412774T1 (de)	2000-02-16	2008-11-15	Illumina Inc	Parallele genotypisierung mehrerer patientenproben
AU2002314734B2 (en)	2001-03-30	2007-08-30	Ge Healthcare Bio-Sciences Ab	P450 single nucleotide polymorphism biochip analysis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8507706D0 (en) *	1985-03-25	1985-05-01	Genetics Int Inc	Magnetic nucleic acid sequences
AU622104B2 (en) *	1987-03-11	1992-04-02	Sangtec Molecular Diagnostics Ab	Method of assaying of nucleic acids, a reagent combination and kit therefore
SE8801070D0 (sv) *	1988-03-23	1988-03-23	Pharmacia Ab	Method for immobilizing a dna sequence on a solid support
NO165894C (no) *	1988-05-24	1991-04-24	Gunnar Paulsen	Analysemetode for gener.
US5817797A (en) *	1988-06-01	1998-10-06	The United States Of America As Represented By The Department Of Health And Human Services	Sequencing DNA; a modification of the polymerase chain reaction

1989
- 1989-11-27 DK DK198905953A patent/DK175170B1/da not_active IP Right Cessation
- 1989-11-27 IL IL9247489A patent/IL92474A/en not_active IP Right Cessation
- 1989-11-28 DE DE68925717T patent/DE68925717T2/de not_active Expired - Fee Related
- 1989-11-28 FI FI895682A patent/FI97153C/fi active IP Right Grant
- 1989-11-28 JP JP1308817A patent/JP2766003B2/ja not_active Expired - Fee Related
- 1989-11-28 ES ES89121895T patent/ES2082766T3/es not_active Expired - Lifetime
- 1989-11-28 EP EP89121895A patent/EP0371437B1/en not_active Expired - Lifetime
- 1989-11-28 CA CA002004056A patent/CA2004056C/en not_active Expired - Fee Related
- 1989-11-28 PT PT92420A patent/PT92420B/pt not_active IP Right Cessation
- 1989-11-28 AT AT89121895T patent/ATE134388T1/de not_active IP Right Cessation
- 1989-11-28 NO NO894746A patent/NO176362C/no unknown
- 1989-11-29 AU AU45749/89A patent/AU623200B2/en not_active Ceased
- 1989-11-29 NZ NZ231576A patent/NZ231576A/en unknown
1996
- 1996-02-23 GR GR960400527T patent/GR3019105T3/el unknown

Also Published As

Publication number	Publication date
CA2004056C (en)	2004-05-11
GR3019105T3 (en)	1996-05-31
EP0371437B1 (en)	1996-02-21
DE68925717T2 (de)	1996-07-04
AU623200B2 (en)	1992-05-07
DK175170B1 (da)	2004-06-21
NO894746L (no)	1990-05-30
JPH02219600A (ja)	1990-09-03
AU4574989A (en)	1990-06-07
FI895682A0 (fi)	1989-11-28
PT92420B (pt)	1995-08-09
EP0371437A3 (en)	1991-03-27
NO176362C (no)	1995-03-22
NO894746D0 (no)	1989-11-28
NO176362B (no)	1994-12-12
CA2004056A1 (en)	1990-05-29
ES2082766T3 (es)	1996-04-01
DK595389A (da)	1990-05-30
FI97153B (fi)	1996-07-15
NZ231576A (en)	1991-12-23
ATE134388T1 (de)	1996-03-15
IL92474A0 (en)	1990-08-31
PT92420A (pt)	1990-05-31
DE68925717D1 (de)	1996-03-28
EP0371437A2 (en)	1990-06-06
FI97153C (fi)	1996-10-25
JP2766003B2 (ja)	1998-06-18
DK595389D0 (da)	1989-11-27

Legal Events

Date	Code	Title
1999-08-17	HP	Change in proprietorship
2000-06-01	KB	Patent renewed
2004-01-04	KB	Patent renewed
2008-11-03	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
EP0371437B1 (en)	1996-02-21	Method and reagent combination for determining nucleotide sequences
US6013431A (en)	2000-01-11	Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
EP0359789B1 (en)	1993-08-04	Amplification and detection of nucleic acid sequences
CA2071537C (en)	2003-02-11	Method and reagent for determining specific nucleotide variations
CA2105060C (en)	2007-05-01	Nucleic acid typing by polymerase extension of oligonucleotides using terminator mixtures
Wu et al.	1989	Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia.
US5834181A (en)	1998-11-10	High throughput screening method for sequences or genetic alterations in nucleic acids
JP2622327B2 (ja)	1997-06-18	核酸配列の増幅手段
US5981176A (en)	1999-11-09	Method of detecting and discriminating between nucleic acid sequences
JP2001501092A (ja)	2001-01-30	Ｄｎａの配列決定法
Syvänen et al.	1989	Direct sequencing of affinity‐captured amplified human DNA application to the detection of apolipoprotein E polymorphism
AU5093001A (en)	2001-10-03	Microarray-based analysis of polynucleotide sequence variations
AU8846898A (en)	1999-03-01	Method and kit for hla class i typing dna
JP2000513202A (ja)	2000-10-10	核酸の塩基配列決定または遺伝的置換の大量スクリーニング法
CA2205234A1 (en)	1997-03-20	High throughput screening method for sequences or genetic alterations in nucleic acids